Literature DB >> 2476945

A case showing sclerosing adenosis and an unusual form of basal cell hyperplasia of the prostate.

B M Ronnett1, J I Epstein.   

Abstract

We describe an unusual case of benign prostatic hyperplasia that demonstrated florid sclerosing adenosis--an uncommon lesion that may be confused with prostate carcinoma. Immunohistochemistry utilizing Keratin 903, a basal cell-specific antikeratin antibody, was useful in identifying basal cells in sclerosing adenosis, thus verifying its benign nature. In addition, this case had an unusual form of basal cell hyperplasia that resembled basaloid carcinomas (adenoid cystic carcinoma) involving the prostate.

Entities:  

Mesh:

Year:  1989        PMID: 2476945     DOI: 10.1097/00000478-198910000-00006

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

1.  Hybrid sclerosing adenosis and basal cell hyperplasia of the prostate.

Authors:  Naoto Kuroda; Kazunobu Katto; Yuji Ohtsuki; Ondrej Hes; Michal Michal; Kaori Inoue; Masahiko Ohara; Keiko Mizuno; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2011-01-26       Impact factor: 2.309

2.  Basal cell adenoma of prostate.

Authors:  E Atik; I Unsal
Journal:  Urol Res       Date:  2004-11-13

3.  Prostate sclerosing adenopathy: A clinicopathological and immunohistochemical study of twelve patients.

Authors:  Run-Lin Feng; Yan-Ping Tao; Zhi-Yong Tan; Shi Fu; Hai-Feng Wang
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

4.  Adenoid-basal cell tumor of the prostate gland. A case report: histomorphologic and immunohistochemical features.

Authors:  Ozden Tulunay; Diclehan Orhan; Cağatay Göğüş; Emre Culha; Yusuf Ziya Müftüoğlu
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

Review 5.  Basaloid cell carcinoma of the prostate.

Authors:  Mauro G Mastropasqua; Giancarlo Pruneri; Giuseppe Renne; Ottavio De Cobelli; Giuseppe Viale
Journal:  Virchows Arch       Date:  2003-12       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.